U-Factorホールディングス株式会社 News Releases

U-Factor Holdings Decides to Adopt Toyota's 'WAVEBASE' for Drug Discovery Using Stem Cell Supernatant 'U-Factor® Fluid'

U-Factor Holdings has decided to adopt Toyota Motor's data analysis system 'WAVEBASE' to enhance dru… · 2026-03-31

U-Factor Holdings Decides to Adopt Toyota's "WAVEBASE" for Drug Discovery Research Using Stem Cell Conditioned Medium "U-Factor®"

U-Factor Holdings has announced the adoption of Toyota Motor Corporation's data analysis system, "WA… · 2026-03-31

U-Factor Holdings Decides to Adopt Toyota's 'WAVEBASE' for Drug Discovery Using Stem Cell Supernatant 'U-Factor® Fluid'

U-Factor Holdings has decided to adopt Toyota Motor's data analysis system 'WAVEBASE' to enhance dru… · 2026-03-31

World's First Prospective Intervention Study on ALS (Amyotrophic Lateral Sclerosis) Using U-Factor® Fluid Presented at Academic Conference

U-Factor Holdings Co., Ltd. announced that Dr. Yasuhiro Seta, Director of Hitonowa Medical and exter… · 2026-04-13

U-Factor Holdings Commences Joint Research with The University of Tokyo Hospital to Develop Drugs from Stem Cell Culture Supernatant 'U-Factor® Liquid'

U-Factor Holdings Co., Ltd. announced a joint research agreement with the Department of Geriatric Me… · 2026-05-15

[World First] U-Factor® liquid used in ALS (Amyotrophic Lateral Sclerosis) prospective intervention study results presented at academic conference

U-Factor Holdings Co., Ltd. announced that Dr. Yasuhiro Seta, Director of Hitonowa Medical, presente… · 2026-04-13

U-Factor Holdings Commences Joint Research with The University of Tokyo Hospital to Develop Drugs from Stem Cell Culture Supernatant 'U-Factor® Liquid'

U-Factor Holdings Co., Ltd. announced a joint research agreement with the Department of Geriatric Me… · 2026-05-15

U-Factor Holdings Decides to Adopt Toyota Motor's "WAVEBASE" for Drug Discovery of Stem Cell Supernatant "U-Factor® Liquid"

U-Factor Holdings has decided to adopt Toyota Motor's data analysis system "WAVEBASE" to strengthen … · 2026-03-31

[World First] U-Factor® liquid used in ALS (Amyotrophic Lateral Sclerosis) prospective intervention study results presented at academic conference

U-Factor Holdings Co., Ltd. announced that Dr. Yasuhiro Seta, Director of Hitonowa Medical, presente… · 2026-04-13

[World First] U-Factor® liquid used in ALS (Amyotrophic Lateral Sclerosis) prospective intervention study results presented at academic conference

U-Factor Holdings Co., Ltd. announced that Dr. Yasuhiro Seta, Director of Hitonowa Medical, presente… · 2026-04-13